200 related articles for article (PubMed ID: 1896396)
1. [Subcutaneous administration of recombinant human erythropoietin (R-EPO) in the treatment of anemia in predialysis patients with chronic renal failure].
Debska-Slizień A; Rutkowski B; Niemierko J; Jankowska-Gan E; Gołebiewska-Zurkowska G; Kabata J; Manitius A
Pol Arch Med Wewn; 1991 Jun; 85(6):334-40. PubMed ID: 1896396
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of erythropoiesis under the influence of recombinant human erythropoietin (R-EPO) in dialyzed patients].
Debska-Slizień A; Kabata J; Rutkowski B; Ciesielski D; Jankowska-Gan E; Manitius A
Pol Arch Med Wewn; 1991 Jun; 85(6):341-51. PubMed ID: 1896397
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
Albertazzi A; Di Liberato L; Daniele F; Battistel V; Colombi L
Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
[TBL] [Abstract][Full Text] [Related]
4. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
5. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
6. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
Boratyńska M; Szewczyk Z; Szepietowski T; Czyz W; Cybulski K; Bogucki J; Szczepański J
Przegl Lek; 1990; 47(11):741-5. PubMed ID: 2098840
[TBL] [Abstract][Full Text] [Related]
7. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
[TBL] [Abstract][Full Text] [Related]
8. Treatment of renal anemia by subcutaneous erythropoietin in children with preterminal chronic renal failure.
Schärer K; Klare B; Braun A; Dressel P; Gretz N
Acta Paediatr; 1993 Nov; 82(11):953-8. PubMed ID: 8111177
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A
Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
[TBL] [Abstract][Full Text] [Related]
10. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
[TBL] [Abstract][Full Text] [Related]
12. [Effect of human recombinant erythropoietin (r-EPO) on behavior of iron status parameters in patients with chronic renal failure treated with dialysis].
Debska-Slizień A; Biedunkiewicz B; Rutkowski B
Pol Arch Med Wewn; 1994 Sep; 92(3):207-15. PubMed ID: 7808929
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation.
Van Biesen W; Vanholder R; Veys N; Verbeke F; Lameire N
Transplantation; 2005 Feb; 79(3):367-8. PubMed ID: 15699772
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in renal transplant recipients with renal anemia.
Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H
Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
16. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients.
Jungers P; Choukroun G; Oualim Z; Robino C; Nguyen AT; Man NK
Nephrol Dial Transplant; 2001 Feb; 16(2):307-12. PubMed ID: 11158405
[TBL] [Abstract][Full Text] [Related]
17. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
[TBL] [Abstract][Full Text] [Related]
18. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.
Kuriyama S; Tomonari H; Yoshida H; Hashimoto T; Kawaguchi Y; Sakai O
Nephron; 1997; 77(2):176-85. PubMed ID: 9346384
[TBL] [Abstract][Full Text] [Related]
19. Comparison of plasma erythropoietin concentrations and iron status in hemodialyzed patients not requiring and requiring rHuEpo therapy.
Majdan M; Ksiazek A; Kozioł M; Spasiewicz D; Swatowski A; Solski J
Nephron; 1996; 73(3):425-9. PubMed ID: 8832602
[TBL] [Abstract][Full Text] [Related]
20. [[Effect of erythropoietin and its combination with hypoxic altitude chamber training on the clinical and functional manifestations of chronic glomerulonephritis].
Kaliev R; Murkamilov IT; Fomin VV; Kaliev KP; Aver'ianova NI
Ter Arkh; 2014; 86(10):40-6. PubMed ID: 25509891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
